RFK Jr's adviser Sara Brenner and NYC oncologist Jeff Vacirca in contention for FDA's leadership positions: Report
Trump administration is considering Sara Brenner and Jeff Vacirca for top FDA roles amid leadership turmoil and efforts to reshape the agency.
The Trump administration is considering Sara Brenner, a senior adviser at the Department of Health and Human Services, and Jeff Vacirca, head of a New York oncology group, for leadership positions at the Food and Drug Administration (FDA) as the agency's top ranks undergo a shakeup. Brenner, who served as the FDA's top deputy in the first Trump administration, is a physician and senior counselor for public health at HHS.
Vacirca, the CEO of New York Cancer & Blood Specialists, has a medical degree from St. George’s University. Both individuals are seen as potential candidates to advance efforts to speed clinical trials and overhaul reviews of drugs to treat rare diseases. The White House has not made any final decisions, and the nomination of White House aide Heidi Overton to serve as FDA commissioner was withdrawn earlier this week.
Brief written by urgent.news from Hindustan Times - World News's own syndicated text. Machine-written; may contain errors — check the original.